Literature DB >> 20105155

Molluscan biological and chemical diversity: secondary metabolites and medicinal resources produced by marine molluscs.

Kirsten Benkendorff1.   

Abstract

The phylum Mollusca represents an enormous diversity of species with eight distinct classes. This review provides a taxonomic breakdown of the published research on marine molluscan natural products and the medicinal products currently derived from molluscs, in order to identify priority targets and strategies for future research. Some marine gastropods and bivalves have been of great interest to natural products chemists, yielding a diversity of chemical classes and several drug leads currently in clinical trials. Molluscs also feature prominently in a broad range of traditional natural medicines, although the active ingredients in the taxa involved are typically unknown. Overall secondary metabolites have only been investigated from a tiny proportion (<1%) of molluscan species. At the class level, the number of species subject to chemical studies mirrors species richness and our relative knowledge of the biology of different taxa. The majority of molluscan natural products research is focused within one of the major groups of gastropods, the opisthobranchs (a subgroup of Heterobranchia), which are primarily comprised of soft-bodied marine molluscs. Conversely, most molluscan medicines are derived from shelled gastropods and bivalves. The complete disregard for several minor classes of molluscs is unjustified based on their evolutionary history and unique life styles, which may have led to novel pathways for secondary metabolism. The Polyplacophora, in particular, have been identified as worthy of future investigation given their use in traditional South African medicines and their abundance in littoral ecosystems. As bioactive compounds are not always constitutively expressed in molluscs, future research should be targeted towards biosynthetic organs and inducible defence reactions for specific medicinal applications. Given the lack of an acquired immune system, the use of bioactive secondary metabolites is likely to be ubiquitous throughout the Mollusca and broadening the search field may uncover interesting novel chemistry.
© 2010 The Author. Biological Reviews © 2010 Cambridge Philosophical Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20105155     DOI: 10.1111/j.1469-185X.2010.00124.x

Source DB:  PubMed          Journal:  Biol Rev Camb Philos Soc        ISSN: 0006-3231


  42 in total

Review 1.  Marine Snails and Slugs: a Great Place To Look for Antiviral Drugs.

Authors:  Vinh T Dang; Kirsten Benkendorff; Tim Green; Peter Speck
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

Review 2.  Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.

Authors:  Maria Letizia Ciavatta; Florence Lefranc; Marianna Carbone; Ernesto Mollo; Margherita Gavagnin; Tania Betancourt; Ramesh Dasari; Alexander Kornienko; Robert Kiss
Journal:  Med Res Rev       Date:  2016-12-07       Impact factor: 12.944

Review 3.  Bioactive Compounds from Marine Heterobranchs.

Authors:  Conxita Avila; Carlos Angulo-Preckler
Journal:  Mar Drugs       Date:  2020-12-21       Impact factor: 5.118

4.  Characterization of the bacterial community of the chemically defended Hawaiian sacoglossan Elysia rufescens.

Authors:  Jeanette Davis; W Florian Fricke; Mark T Hamann; Eduardo Esquenazi; Pieter C Dorrestein; Russell T Hill
Journal:  Appl Environ Microbiol       Date:  2013-09-06       Impact factor: 4.792

Review 5.  High-value compounds from the molluscs of marine and estuarine ecosystems as prospective functional food ingredients: An overview.

Authors:  Kajal Chakraborty; Minju Joy
Journal:  Food Res Int       Date:  2020-08-31       Impact factor: 6.475

6.  The Ethyl Acetate Extract of the Marine Edible Gastropod Haliotis tuberculata coccinea: a Potential Source of Bioactive Compounds.

Authors:  Emiliana Tortorella; Rosa Giugliano; Marleen De Troch; Bruno Vlaeminck; Gercende Courtois de Viçose; Donatella de Pascale
Journal:  Mar Biotechnol (NY)       Date:  2021-10-29       Impact factor: 3.619

7.  A bacterial source for mollusk pyrone polyketides.

Authors:  Zhenjian Lin; Joshua P Torres; Mary Anne Ammon; Lenny Marett; Russell W Teichert; Christopher A Reilly; Jason C Kwan; Ronald W Hughen; Malem Flores; Ma Diarey Tianero; Olivier Peraud; James E Cox; Alan R Light; Aaron Joseph L Villaraza; Margo G Haygood; Gisela P Concepcion; Baldomero M Olivera; Eric W Schmidt
Journal:  Chem Biol       Date:  2013-01-24

8.  Dactyloditerpenol acetate, a new prenylbisabolane-type diterpene from Aplysia dactylomela with significant in vitro anti-neuroinflammatory activity.

Authors:  Carlos Jiménez-Romero; Alejandro M S Mayer; Abimael D Rodríguez
Journal:  Bioorg Med Chem Lett       Date:  2013-11-14       Impact factor: 2.823

9.  Marine compounds selectively induce apoptosis in female reproductive cancer cells but not in primary-derived human reproductive granulosa cells.

Authors:  Vicki Edwards; Kirsten Benkendorff; Fiona Young
Journal:  Mar Drugs       Date:  2012-01-10       Impact factor: 6.085

Review 10.  Are the Traditional Medical Uses of Muricidae Molluscs Substantiated by Their Pharmacological Properties and Bioactive Compounds?

Authors:  Kirsten Benkendorff; David Rudd; Bijayalakshmi Devi Nongmaithem; Lei Liu; Fiona Young; Vicki Edwards; Cathy Avila; Catherine A Abbott
Journal:  Mar Drugs       Date:  2015-08-18       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.